SHIPPEO
23.3.2022 11:05:05 CET | Business Wire | Press release
UNILIN , a Belgian manufacturer of flooring, panels and insulation products for the home, has chosen Shippeo , a global leader and European specialist in real-time transportation visibility, to boost service and savings.
Headquartered in Belgium, UNILIN owns 15 powerful brands (including the Quickstep flooring brand) and distributes its products in over 23 countries throughout Europe. The company operates eight key loading sites, consisting of plants, warehouses and a cross dock, and makes over 100,000 deliveries per year to specialised DIY and building supplies retailers via a network of 20 carrier partners.
A lack of visibility of external transport quality, lead times and proof of delivery led UNILIN to look for a solution that would help with supply chain optimisation and the streamlining of processes, thereby improving customer service and enabling the company to stay competitive in its market.
By implementing Shippeo’s real-time transportation visibility solution to collect location data for all deliveries, UNILIN was able to proactively inform customers about potential delays. Shippeo’s advanced ability to track Less-than-Truckload (LTL) was critical, as LTL is UNILIN’s main and most complex transportation method. Shippeo’s solution has been specifically engineered to overcome tracking challenges associated with LTL by using advanced integrations with carriers’ Transportation Management Systems (TMS) and highly accurate geofencing techniques. The live location data captured, along with automatically generated proofs of delivery, is accessible to users on the Shippeo platform portal. Delivery status information provided by Shippeo will also be made available to UNILIN customers via their own customer portal.
Following the success of the first business use case for real-time transportation visibility, UNILIN is now exploring taking advantage of Shippeo’s mobile application for more granular visibility of own fleet shipments thanks to its parcel scanning capabilities.
Shippeo’s Dennis van Bodegom, Director Northern Europe, is thrilled to be working with UNILIN: “Our organisations both share a strong commitment to excellence in service, and I’m sure Shippeo’s real-time visibility and predictive capabilities will lead to an optimised and proactive supply chain, for the benefit of UNILIN as well as their customers.”
Geert van Damme, Transport & Distribution Manager at UNILIN, said: “I did some market studies and a lot of companies came up with ideas. But the only one who could convince me to do a proof of concept was Shippeo. The ability to automatically provide our customers with real-time tracking for all our LTL deliveries is a game changer. The level of data and insight we now have access to also brings much more clarity around our delivery performance.”
About Shippeo (https://www.shippeo.com
)
LinkedIn, Facebook, Twitter
Shippeo, a global leader and European specialist in real-time transportation visibility, helps major shippers and logistics service providers leverage transportation to deliver exceptional customer service and achieve operational excellence. Their Multimodal Visibility Network connects FTL, LTL, parcel, and container transport and integrates 875+ TMS, telematics and ELD systems using a unique API. The Shippeo platform provides instant access to real-time delivery tracking, automates customer processes and offers unmatched ETA accuracy thanks to a proprietary and industry-leading algorithm developed in-house. Over 100 customers, including global brands like Coca-Cola HBC, Carrefour, Schneider Electric, Total, Faurecia, Saint-Gobain and Eckes Granini, trust Shippeo to track more than 28 million shipments per year across 75 countries.
About Unilin (https://www.unilin.com
)
Unilin Group is a global reference for interior design and building. The company engineers, manufactures and markets laminate flooring, luxury vinyl tiles, sheet vinyl, engineered parquet, carpet tiles, broadloom carpet, raw and decorative panels, industrial floors, wall and roof systems and insulation boards. Unilin employs 7.500 people at 105 locations all over the globe, 30 of which are production sites. In 2020, Unilin achieved a turnover of €2.21 billion. Customers and partners know the company as Unilin, IVC or Godfrey Hirst, or through one of its brands, such as Quick-Step, Moduleo, Utherm, Pergo, Evola, Xtratherm or ClicWall. Unilin Group is proudly part of Mohawk Industries, the world's largest flooring company with a turnover of $ 10 billion and 41.600 employees.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220322005915/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom